Ergoline compounds, their preparation and pharmaceutical compositions containing them
申请人:ELI LILLY AND COMPANY
公开号:EP0003667A1
公开(公告)日:1979-08-22
Novel ergoline compounds of the following formula are described:
wherein R1 is ethyl, n-propyl, or allyl; Y is O, S, SO, or SO2; X is hydrogen, chloro, or bromo; the dotted line represents the optional presence of a double bond; and the pharmaceutically-acceptable acid addition salts thereof. The compounds are useful to inhibit prolactin secretion or to treat Parkinson's syndrome.
描述了下式的新型麦角啉化合物:
其中 R1 是乙基、正丙基或烯丙基;Y 是 O、S、SO 或 SO2;X 是氢、氯或溴;虚线表示任选存在的双键;及其药学上可接受的酸加成盐。这些化合物可用于抑制催乳素分泌或治疗帕金森综合症。